Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma
- Author(s)
- Iacoboni, G; Kyvsgaard, ER; Navarro Garcés, V; Lewis, K; Russler-Germain, DA; Martín García-Sancho, A; Quintela, D; Gómez, P; Carro, I; Valencia, E; Thompson, PA; Bastos-Oreiro, M; Therwhanger, D; Serna, A; De La Cruz, B; Ku, M; Cabero, A; Canales, M; Schuster, S; Vega, G; Jiménez-Ubieto, A; Husby, S; Luan, J; Camarillas, S; Medina, L; Córdoba, R; Sancho, JM; Bosch, F; Sureda, A; Cheah, CY; Hutchings, M; Barba, P; Abrisqueta, P;
- Details
- Publication Year 2026-03-24,Volume 10,Issue #6,Page 1947-1951
- Journal Title
- Blood Advances
- Publication Type
- Research article
- Publisher
- American Society of Hematology
- Department(s)
- Haematology
- Publisher's Version
- https://doi.org/10.1182/bloodadvances.2025018546
- Open Access at Publisher's Site
https://doi.org/10.1182/bloodadvances.2025018546- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2026-01-20 05:38:40
Last Modified: 2026-04-02 06:01:40